Cargando…
Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic
OBJECTIVES: Sacral neuromodulation is an effective, minimally invasive treatment for refractory lower urinary tract dysfunction. However, regular postoperative programming is crucial for the maintenance of the curative effects of electronic sacral stimulator devices. The outbreak of coronavirus dise...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081490/ https://www.ncbi.nlm.nih.gov/pubmed/37035299 http://dx.doi.org/10.3389/fmed.2023.977433 |
_version_ | 1785021136594010112 |
---|---|
author | Meng, Lingfeng Hou, Huimin Zhang, Peng Gu, Yinjun Shi, Benkang Li, Yan Wang, Qingwei Zhang, Yifei Ren, Lijuan Chen, Qi Yuan, Zhen Guo, Fan Li, Dianyou Ma, Yunfu Dong, Sheng Liu, Zhijun Shang, Aijia Li, Bo Xu, Wei Lv, Jianwei Zhang, Yaoguang |
author_facet | Meng, Lingfeng Hou, Huimin Zhang, Peng Gu, Yinjun Shi, Benkang Li, Yan Wang, Qingwei Zhang, Yifei Ren, Lijuan Chen, Qi Yuan, Zhen Guo, Fan Li, Dianyou Ma, Yunfu Dong, Sheng Liu, Zhijun Shang, Aijia Li, Bo Xu, Wei Lv, Jianwei Zhang, Yaoguang |
author_sort | Meng, Lingfeng |
collection | PubMed |
description | OBJECTIVES: Sacral neuromodulation is an effective, minimally invasive treatment for refractory lower urinary tract dysfunction. However, regular postoperative programming is crucial for the maintenance of the curative effects of electronic sacral stimulator devices. The outbreak of coronavirus disease 2019 (COVID-19) limited the ability of practitioners to perform traditional face-to-face programming of these stimulators. Therefore, this study aimed to evaluate the application of remote programming technology for sacral neuromodulation during the COVID-19 pandemic in China. MATERIALS AND METHODS: We retrospectively collected data including baseline and programming information of all patients with lower urinary tract dysfunction who underwent sacral neuromodulation remote programming in China after the outbreak of COVID-19 (i.e., December 2019). The patients also completed a self-designed telephone questionnaire on the subject. RESULTS: A total of 51 patients from 16 centers were included. They underwent 180 total remote programming visits, and 118, 2, 25, and 54 voltage, current, pulse width, and frequency adjustments, respectively, were performed. Additionally, remote switching on and off was performed 8 times; impedance test, 54 times; and stimulation contact replacement, 25 times. The demand for remote programming was the highest during the first 6 months of sacral neuromodulation (average, 2.39 times per person). In total, 36 out of the 51 patients completed the questionnaire survey. Of these, all indicated that they chose remote programming to minimize unnecessary travel because they had been affected by COVID-19. The questionnaire also showed that remote programming could reduce the number of patient visits to the hospital, save time, reduce financial costs, and would be easy for patients to master. All surveyed patients indicated that they were satisfied with remote programming and were willing to recommend it to other patients. CONCLUSION: Remote programming for sacral neuromodulation is feasible, effective, safe, and highly recommended by patients with refractory lower urinary tract dysfunction. Remote programming technology has great development and application potential in the post-pandemic era. |
format | Online Article Text |
id | pubmed-10081490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100814902023-04-08 Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic Meng, Lingfeng Hou, Huimin Zhang, Peng Gu, Yinjun Shi, Benkang Li, Yan Wang, Qingwei Zhang, Yifei Ren, Lijuan Chen, Qi Yuan, Zhen Guo, Fan Li, Dianyou Ma, Yunfu Dong, Sheng Liu, Zhijun Shang, Aijia Li, Bo Xu, Wei Lv, Jianwei Zhang, Yaoguang Front Med (Lausanne) Medicine OBJECTIVES: Sacral neuromodulation is an effective, minimally invasive treatment for refractory lower urinary tract dysfunction. However, regular postoperative programming is crucial for the maintenance of the curative effects of electronic sacral stimulator devices. The outbreak of coronavirus disease 2019 (COVID-19) limited the ability of practitioners to perform traditional face-to-face programming of these stimulators. Therefore, this study aimed to evaluate the application of remote programming technology for sacral neuromodulation during the COVID-19 pandemic in China. MATERIALS AND METHODS: We retrospectively collected data including baseline and programming information of all patients with lower urinary tract dysfunction who underwent sacral neuromodulation remote programming in China after the outbreak of COVID-19 (i.e., December 2019). The patients also completed a self-designed telephone questionnaire on the subject. RESULTS: A total of 51 patients from 16 centers were included. They underwent 180 total remote programming visits, and 118, 2, 25, and 54 voltage, current, pulse width, and frequency adjustments, respectively, were performed. Additionally, remote switching on and off was performed 8 times; impedance test, 54 times; and stimulation contact replacement, 25 times. The demand for remote programming was the highest during the first 6 months of sacral neuromodulation (average, 2.39 times per person). In total, 36 out of the 51 patients completed the questionnaire survey. Of these, all indicated that they chose remote programming to minimize unnecessary travel because they had been affected by COVID-19. The questionnaire also showed that remote programming could reduce the number of patient visits to the hospital, save time, reduce financial costs, and would be easy for patients to master. All surveyed patients indicated that they were satisfied with remote programming and were willing to recommend it to other patients. CONCLUSION: Remote programming for sacral neuromodulation is feasible, effective, safe, and highly recommended by patients with refractory lower urinary tract dysfunction. Remote programming technology has great development and application potential in the post-pandemic era. Frontiers Media S.A. 2023-03-13 /pmc/articles/PMC10081490/ /pubmed/37035299 http://dx.doi.org/10.3389/fmed.2023.977433 Text en Copyright © 2023 Meng, Hou, Zhang, Gu, Shi, Li, Wang, Zhang, Ren, Chen, Yuan, Guo, Li, Ma, Dong, Liu, Shang, Li, Xu, Lv and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Meng, Lingfeng Hou, Huimin Zhang, Peng Gu, Yinjun Shi, Benkang Li, Yan Wang, Qingwei Zhang, Yifei Ren, Lijuan Chen, Qi Yuan, Zhen Guo, Fan Li, Dianyou Ma, Yunfu Dong, Sheng Liu, Zhijun Shang, Aijia Li, Bo Xu, Wei Lv, Jianwei Zhang, Yaoguang Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic |
title | Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic |
title_full | Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic |
title_fullStr | Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic |
title_full_unstemmed | Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic |
title_short | Sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: China’s experience during the COVID-19 pandemic |
title_sort | sacral neuromodulation remote programming in patients with refractory lower urinary tract dysfunction: china’s experience during the covid-19 pandemic |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081490/ https://www.ncbi.nlm.nih.gov/pubmed/37035299 http://dx.doi.org/10.3389/fmed.2023.977433 |
work_keys_str_mv | AT menglingfeng sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT houhuimin sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT zhangpeng sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT guyinjun sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT shibenkang sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT liyan sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT wangqingwei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT zhangyifei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT renlijuan sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT chenqi sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT yuanzhen sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT guofan sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT lidianyou sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT mayunfu sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT dongsheng sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT liuzhijun sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT shangaijia sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT libo sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT xuwei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT lvjianwei sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic AT zhangyaoguang sacralneuromodulationremoteprogramminginpatientswithrefractorylowerurinarytractdysfunctionchinasexperienceduringthecovid19pandemic |